Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-018 - Number of Cancer Cells in Lung Adenocarcinoma Specimen – Correlation with Noguchi's Classification, WHO Pathologic Type, and Prognosis
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): Y. Nakazato, M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-007 - Interleukin-17A Promotes Lung Tumor Progression Through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.
09:30 - 09:30 | Presenter: Esra A Akbay | Author(s): S. Koyama, G. Dranoff, Kwok-Kin Wong
- Abstract
Loading... -
+
P1.07-019 - Immune Cell Infiltrates in Non-Small Cell Lung Cancer and Interleukin-22 Expression
09:30 - 09:30 | Presenter: Rudolf M Huber | Author(s): J. Stump, S. Reu, C. Ballesteros-Merino, C. Karches, J.S. Gosálvez, A. Tufman, S. Kobold, J. Neumann, Z. Feng, R. Hatz, R.E. Sanborn, John R Handy, B.A. Fox, C.B. Bifulco, H. Winter
- Abstract
Loading...
-
+
MS 07 - Neuroendocrine Tumors other than SCLC: Pathology to Patient Management
- 15:45 - 17:30
- 10/16/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: SCLC/Neuroendocrine Tumors
- Moderators:C. Barrios, Sang-We Kim
-
+
MS 07.04 - Surgical Treatment for Neuroendocrine Tumors other than SCLC
16:30 - 16:45 | Presenter: Akira Iyoda | Author(s): Yoko Azuma, T. Makino, H. Otsuka, S. Koezuka, N. Tochigi, K. Shibuya, T. Mikami, Kazutoshi Isobe, S. Homma
- Abstract
Loading...
-
+
OA 04 - Surgery from Minimal to Radical
- 15:45 - 17:30
- 10/16/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Surgery
-
+
OA 04.08 - Is Lobe-Specific Lymph Node Dissection in Clinical N0-1 Non-Small Cell Lung Cancer Adequate for Pathological Nodal Staging
17:00 - 17:10 | Presenter: Apichat Tantraworasin | Author(s): S. Siwachat, N. Lertprasertsuke, S. Kongkarnka, J. Euathrongchit, Y. Wannasopha, N. Tanatip, E. Taioli, S. Saeteng
- Abstract
Loading...
-
+
OA 06 - Global Tobacco Control and Epidemiology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Oral
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
OA 06.07 - Survival Trends Among Non-Small Cell Lung Cancer (NSCLC) Patients Over A Decade: Impact of Initial Therapy at Academic Centers
16:50 - 17:00 | Presenter: Yanyan Lou | Author(s): Bhagirathbhai Dholaria, S. Ailawadhi, A.E. Soyano, D. Hodge, R. Manochakian, M.E. Menefee, E. Johnson, M. Thomas, S. Ko, R.C. Miller, M. Johnson, N. Patel, K. Mody, R. Joseph
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-043 - A Phase 1b Study of Erlotinib and Momelotinib for TKI-Naïve EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sukhmani Kaur Padda | Author(s): Karen L Reckamp, M. Koczywas, Joel W. Neal, J. Kawashima, S. Kong, Y. Xin, D. Huang, Heather A Wakelee
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-009 - Monitoring Nivolumab Binding as a Method to Clarify the Residual Therapeutic Effects in Previously Treated Lung Cancer Patients
09:30 - 09:30 | Presenter: Akio Osa | Author(s): S. Koyama, T. Uenami, K. Fujimoto, Y. Naito, H. Hirata, T. Takimoto, I. Nagatomo, Y. Takeda, H. Kida, M. Mori, T. Kijima, A. Kumanogoh
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-064 - Detection of EGFR Mutations in Circulating Tumor DNA Using Plasma Samples: Clinical Validation of Cobas EGFR Mutation Test V2
09:30 - 09:30 | Presenter: Hidetoshi Itani | Author(s): K. Iwamoto, Y. Ito, H. Sasano, S. Kondo, M. Tanigawa
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P3.02-023 - Semaphorin 7A Reduces Response to EGFR-TKI Treatment via Apoptosis in Human Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yuhei Kinehara | Author(s): I. Nagatomo, S. Koyama, A. Kumanogoh
- Abstract
Loading... -
+
P3.02-064 - Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-025 - Tumor Biomarkers for the Routine Care of Advanced Non-Small-Cell Lung Cancer: A Decade of Experience in Implementing Predictive Genomic Events
09:30 - 09:30 | Presenter: Paul Andrew Vanderlaan | Author(s): D. Rangachari, X. Le, A. Majid, M.S. Parikh, S.P. Gangadharan, M.S. Kent, M. Huberman, S.S. Kobayashi, D.B. Costa
- Abstract
Loading...